Clinical Trials Directory

Trials / Completed

CompletedNCT03531554

Acute Nutritional Ketosis in VLCAD Deficiency

Acute Nutritional Ketosis in VLCAD Deficiency: Testing the Metabolic Base for Therapeutic Use

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
University Medical Center Groningen · Academic / Other
Sex
All
Age
16 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To test if a ketone-ester based drink can boost muscle mitochondrial function in vivo in patients with VLCADD in order to establish a rational basis for therapeutic use in this disorder.

Detailed description

Exertional rhabdomyolysis is a common symptom in very long-chain acylCoA dehydrogenase deficient (VLCADD) patients. Failing muscle ATP homeostasis, due to impaired fatty acid oxidation, is the most likely cause. Therefore, supplementation with an alternative energy substrate to boost ATP homeostasis, such as an exogenous ketone ester (KE) drink, could be a therapeutic option. Previous results suggest that KE is preferentially oxidized in the tricyclic acid (TCA) cycle and improves physical endurance in athletes. Our primary objective is to test if KE boosts muscular ATP homeostasis in VLCADD patients to establish a rational basis for therapeutic use. VLCADD patients will be included in a randomized, blinded, placebo controlled, 2-way cross-over trial. Prior to each test, patients receive a KE drink or an isocaloric carbohydrate equivalent, and completed a 35 min cycling test on an upright bicycle, followed by 10 minutes of supine cycling inside a MR scanner. The protocol will be repeated after at least one week with the opposite drink.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTketone ester drink395 mg of ketone ester/kg
BEHAVIORALexercise35 min cycling test on an upright bicycle, followed by 10 minutes of supine cycling inside a MR scanner.
PROCEDUREmuscle biopsybiopsy from the quadriceps muscle prior to and immediately after upright bicycling
DIAGNOSTIC_TESTMagnetic Resonance Imaging1H MR images and 31P MR spectra were acquired from the upper leg prior to-, during and after exercise

Timeline

Start date
2016-04-01
Primary completion
2017-03-31
Completion
2017-04-01
First posted
2018-05-21
Last updated
2018-05-21

Locations

2 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03531554. Inclusion in this directory is not an endorsement.